Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|January 1, 1993
Antioxidant activity of plasma from subjects with and without senile cataractG Tissié, S Flangakis, L Missotten, et al.
American Journal of Clinical Oncology|December 15, 2004
Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter studyDominique Genet, D Cupissol, G Calais, et al.
Bulletin Du Cancer|October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]H Bourgeois, F Turpin, M Bouchada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trialJ-M Ferrero, B Weber, J-F Geay, et al.
The British Journal of Ophthalmology|January 20, 1999
Case-control study of the risk factors for age related macular degeneration. France-DMLA Study GroupG Chaine, A Hullo, J Sahel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerJ L Misset, V Dieras, G Gruia, et al.
Diseases of the Colon and Rectum|February 1, 1991
A rare cause of colitis--Brucella melitensis. Report of a caseP G Jorens, P P Michielsen, E J Van den Enden, et al.
BMC Cancer|October 24, 2021
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocolM Chartogne, A Leclercq, B Beaune, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experienceJ Bonneterre, M Spielman, J P Guastalla, et al.
Pageof 4